期刊文献+

^(18)F-FDG PET、CT及PET/CT对肝脏恶性肿瘤射频消融术后残余瘤诊断的Meta分析 被引量:5

Detecting of residual tumor after radiofrequency ablation of hepatic malignancies by using ^(18)F-FDG PET,PET/CT and CT: a Meta-analysis
暂未订购
导出
摘要 目的:探讨用Meta分析方法评价18F-FDG PET、CT及PET/CT对肝脏恶性肿瘤射频消融术后残余瘤的诊断价值。方法:电子检索PubMed、EBSCO、Springer、Ovid和CNKI以及Cochrane图书馆数据库,文献检索起止时间均从建库至2010年4月,同时检索纳入文献的参考文献。纳入有关评价18F-FDG PET、CT及PET/CT对肝脏恶性肿瘤射频消融术后残余瘤诊断价值的文献,并逐个进行质量评价和资料提取。采用MetaDiSc1.4软件对数据进行分析,并探讨影响诊断效能的因素。结果:符合纳入标准的文献共12篇,各研究之间存在异质性,按照随机效应模型计算,CT汇总特异度最高为0.93(95%CI:0.91~0.95);PET/CT汇总敏感度最高为0.90(95%CI:0.86~0.94)。18F-FDG PET、CT及PET/CT汇总诊断比值比分别为0.9037、0.7372及0.9142。PET和PET/CT在敏感度、特异度及诊断比值比上均无统计学差异。而CT由于受病灶周围炎症反应的影响而诊断准确率降低。另外肿瘤的组织学类型及术后复查时间影响PET及PET/CT的诊断价值。结论:PET与PET/CT对肝脏恶性肿瘤射频消融术后残余瘤诊断准确率优于CT,对于肝转移癌优势更加显著,术后早期复查是提高诊断准确率的有效手段。 Objective: To perform a Meta-analysis comparing current noninvasive imaging methods[18F fluorodeoxyglucose(FDG) positron emission tomography(PET),PET/CT,and CT] in the detection of residual tumor after radiofrequency ablation of hepatic malignancies.Materials and Methods: MEDLINE,EMBASE,Cochrane library and some other databases,from January 1966 to April 2010,were searched for initial studies.All the studies published in English or Chinese relating to the diagnostic value of 18F-FDG PET,PET/CT,and CT for patients with residual tumor after radiofrequency ablation of hepatic malignancies were collected.Methodological quality was assessed.The statistic software called 'Meta-Disc 1.4' was used for data analysis.A covariate analysis was used to evaluate the influence of patient or study-related factors on sensitivity.Results: In 12 included studies,CT had the highest pooled specificity,0.93(95%CI: 0.91~0.95);PET/CT had highest pooled sensitivity,0.90(95%CI: 0.86~0.94).The AUC of PET,PET/CT and CT were 0.9037,0.7372 and 0.9142 respectively.The pooled sensitivity,pooled specificity and AUC showed no statistical significance between PET alone and PET/CT.For CT,its diagnostic value decreased in differentiating residual tumor for patients with inflammatory reaction around the lesion.The pathological types of liver tumors also affect the diagnostic value of PET and PET/CT.There was heterogeneity among studies and evidence of publication bias.Conclusion: 18F-FDG PET and PET/CT can provide added diagnostic information compared with CT in patients after radiofrequency ablation of hepatic malignancies.FDG-PET/CT is a more sensitive method in the follow-up of hepatic malignancies after radiofrequency ablation,particularly in patients with liver metastases.
出处 《中国临床医学影像杂志》 CAS 北大核心 2010年第11期774-777,共4页 Journal of China Clinic Medical Imaging
  • 相关文献

参考文献4

  • 1畅智慧,刘兆玉,李剑明,孙洪赞,单明.^(18)F-FDG PET/CT显像在肝脏恶性肿瘤介入治疗后的临床应用价值[J].中国临床医学影像杂志,2008,19(9):642-645. 被引量:8
  • 2范卫君,赵明,吴沛宏,张福君,黄金华,李立,徐志斌,莫运仙,顾仰葵.经皮射频消融术在肝脏肿瘤治疗中的临床价值[J].中华放射学杂志,2002,36(4):313-316. 被引量:48
  • 3Patrick Veit,Gerald Antoch,Hrvoje Stergar,Andreas Bockisch,Michael Forsting,Hilmar Kuehl. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results[J] 2006,European Radiology(1):80~87
  • 4Marc Giovannini M.D.,Vincent Moutardier M.D.,Carcline Danisi M.D.,Erwan Bories M.D.,Christian Pesenti M.D.,Jean-Robert Delpéro M.D.. Treatment of hepatocellular carcinoma using percutaneous radiofrequency thermoablation: Results and outcomes in 56 patients[J] 2003,Journal of Gastrointestinal Surgery(6):791~796

二级参考文献15

  • 1赵明,吴沛宏,曾益新,张福君,黄金华,范卫君,顾仰葵,张亮,谭志斌,林尤恩.^(18)FDG-PET/CT对评价TACE联合RFA治疗原发性肝癌的效果的价值[J].癌症,2005,24(9):1118-1123. 被引量:17
  • 2Coleman RE. PET in lung cancer[J]. J Nucl Med, 1990, 40:814- 820.
  • 3Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy [J]. Int J Radiat Oncol Biol Phys, 1993,27:455-464.
  • 4Thanos L, Mylona S, Galani P, et al. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels [J]. Diagn lnterv Radiol, 2008, 14:51-56.
  • 5Rose DM, Allegra DP, Bostick PJ, et al. Radiofrequency ablation: a novel primary and adjunctive ablative technique for hepatic malignancies[J]. Am Surg, 1999, 65(11) : 1009-1014.
  • 6Cheng MF, Wi YW, Tzen KY, et al. Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment[J]. Neoplasm, 2007, 54(4):342-347.
  • 7Lin YW, Tsai SC, Hung GU. Value of delayed ^18F-FDG PET imaging in the detection of hepatocellular carcinoma[J]. Nucl Med Commnn, 2005, 26:315-321.
  • 8Okuma T, Matsuoka T, PET for monitoring radiofrequency ablation [J]. J Nucl Med, 2006, Okamura T, et al. ^18F-FDG smaU-animal the therapeutic effect of CT -guided on implanted VX2 lung tumors in rabbits 47:1351-1358.
  • 9Ludwig V, Hopper OW, Martin WH, et al. ^18F-FDG PET/CT surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case raport[J]. Am Surg, 2003, 69(7): 593-598.
  • 10Anderson GS, Brinkmann F, Soulen MC, et al. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation[J]. Clin Nucl Med, 2003, 28 (3): 192-197.

共引文献53

同被引文献114

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部